All In Biotech

Drug Trial Radar · NCT06857955

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

A Randomized, Double-blind, Placebo-controlled, Multicenter, 12 Months Treatment Duration, Dose Finding Study, to Evaluate Efficacy, Safety and Pharmacodynamics of QCZ484 in Mild to Moderate Hypertensive Patients

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 396 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

396

Actual

Start

Mar 26, 2025

Primary completion

Sep 17, 2026

Study completion Apr 5, 2028

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Mar 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hypertension

Conditions

  • Hypertension

Interventions

  • SalineOther

    0.9% sodium chloride saline solution

  • QCZ484Drug

    Solution of Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Mean 24hr SBP by ABPMTime frame: Baseline, Month 3

Locations

72 sites in 3 countries. Site status is shown where the registry gives one.

  • SEC Clinical Research LLC

    Andalusia, Alabama

  • Longwood Research

    Huntsville, Alabama

  • The Center for Clinical Trials

    Saraland, Alabama

  • Elite Clinical Studies

    Phoenix, Arizona

  • Synexus Clinical Research US Inc

    Tucson, Arizona

  • NICRs Research Center

    Garden Grove, California

  • Valiance Clinical Research

    Huntington Park, California

  • Downtown L A Research Center Inc

    Los Angeles, California

  • Headlands Research Sacramento

    Sacramento, California

  • Encompass Clinical Research

    Spring Valley, California

  • Clinical Research of Brandon LLC

    Brandon, Florida

  • ALL Medical Research LLC

    Cooper City, Florida

  • National Research Institute

    Hialeah, Florida

  • Cen Exel RCA

    Hollywood, Florida

  • East Coast Institute for Research

    Jacksonville, Florida

  • Entrust Clinical Research

    Miami, Florida

  • Inpatient Research Clinical LLC

    Miami Lakes, Florida

  • Renstar Medical Research

    Ocala, Florida

  • American Research Centers of FL

    Pembroke Pines, Florida

  • Cen Exel FCR

    Tampa, Florida

  • Cardiology Partners Clinical Research Institute

    Wellington, Florida

  • Centricity Research

    Columbus, Georgia

  • Javara Research

    Fayetteville, Georgia

  • Velocity Clinical Research

    Savannah, Georgia

  • Solaris Clinical Research

    Meridian, Idaho

  • Cedar Crosse Research Ct

    Chicago, Illinois

  • Eagle Clinical Research

    Chicago, Illinois

  • Synexus Clinical Research US

    Evansville, Indiana

  • Velocity Clin Research Sioux City

    Sioux City, Iowa

  • Alliance for Multispecialty Research

    Wichita, Kansas

  • Velocity Clinical Res Baton Rouge

    Baton Rouge, Louisiana

  • Southern Clin Research Clinic

    Zachary, Louisiana

  • Ascension Saint Agnes Heart Care

    Baltimore, Maryland

  • Anderson Medical Research

    Ft. Washington, Maryland

  • Capitol Cardiology Associates

    Lanham, Maryland

  • AA Medical Research Center

    Flint, Michigan

  • Oakland Medical Research Center

    Troy, Michigan

  • Synexus Clinical Research US Inc

    Richfield, Minnesota

  • Healthcare Research Network II LLC

    Hazelwood, Missouri

  • Jefferson City Medical Group

    Jefferson City, Missouri

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.